rs61361928

This is a variant in the UGT2B7 gene that changes a leucine to an proline.

GWAS Catalog Trait Associations (5)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

AR-C124910XX measurement

Varenhorst C et al. Effect of genetic variations on ticagrelor plasma levels and clinical outcomes. European Heart Journal 36(29):1901-12 (2015)
Allele T
OR 0.39
p 8.0e-14
N 1,812
Large GWAS
multi-ancestry

gamma-CEHC measurement

Allele T
OR 0.45
p 9.0e-11
N 14,296
Large GWAS
European

total cholesterol measurement

Sinnott-Armstrong N et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nature Genetics 53(2):185-194 (2021)
Allele C
OR 0.10
p 7.0e-10
N 355,858
Major Consortium StudyLarge GWAS
multi-ancestry

low density lipoprotein cholesterol measurement

Sinnott-Armstrong N et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nature Genetics 53(2):185-194 (2021)
Allele C
OR 0.10
p 4.0e-9
N 355,197
Major Consortium StudyLarge GWAS
multi-ancestry

ClinVar annotation

Drug Response☆☆☆
2 submitters1 publication

Tramadol response

View on ClinVar →

About UGT2B7

The protein encoded by this gene belongs to the UDP-glycosyltransferase (UGT) family. UGTs serve a major role in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This protein is localized in the microsome membrane, and has unique specificity for 3,4-catechol estrogens and estriol, suggesting that it may play an important role in regulating the level and activity of these potent estrogen metabolites. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017]

View all UGT2B7 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…